Mylan Institutional, Inc.: Drug Recall
Recall #D-0132-2025 · 11/19/2024
Class II: Risk
Recall Details
- Recall Number
- D-0132-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Mylan Institutional, Inc.
- Status
- Ongoing
- Date Initiated
- 11/19/2024
- Location
- Rockford, IL, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 988 cartons
Reason for Recall
Subpotent and Superpotent Drug
Product Description
Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-039-20
Distribution Pattern
Nationwide in the USA.
Other Recalls by Mylan Institutional, Inc.
- Class II: Risk 03/07/2025
- Class II: Risk 03/07/2025
- Class II: Risk 11/19/2024
- Class II: Risk 11/19/2024
- Class II: Risk 11/19/2024
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.